Lanean...
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
Elevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are ch...
Gorde:
| Argitaratua izan da: | Cardiovasc Ther |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587798/ https://ncbi.nlm.nih.gov/pubmed/30358114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1755-5922.12471 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|